| 8.1 Cohort studies |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
Subtotals only |
| 8.1.1 Within 1 week after vaccination MMR |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
2.45 [2.21, 2.71] |
| 8.1.2 Between 1 to 2 weeks after vaccination MMR |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
3.16 [2.89, 3.46] |
| 8.1.3 > 2 weeks after vaccination MMR |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
0.97 [0.49, 1.94] |
| 8.2 Self‐controlled case series/person‐time cohort |
6 |
|
Rate Ratio (IV, Random, 95% CI) |
Subtotals only |
| 8.2.1 Between 1 to 2 weeks after vaccination MMR |
5 |
|
Rate Ratio (IV, Random, 95% CI) |
3.36 [2.65, 4.24] |
| 8.2.2 > 2 weeks after vaccination MMR |
3 |
|
Rate Ratio (IV, Random, 95% CI) |
1.18 [0.93, 1.50] |
| 8.2.3 Between 1 to 2 weeks after vaccination; MMRV |
2 |
|
Rate Ratio (IV, Random, 95% CI) |
6.08 [4.95, 7.47] |
| 8.2.4 between 1 to 2 weeks after vaccination MMR+V |
1 |
|
Rate Ratio (IV, Random, 95% CI) |
3.13 [2.38, 4.10] |
| 8.3 MMRV versus MMR+V |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
| 8.3.1 from 0 to 42 days after vaccination |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
1.31 [1.19, 1.45] |
| 8.3.2 from 7 to 10 days after vaccination |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
1.98 [1.69, 2.33] |
| 8.4 MMRV versus MMR+V ‐ by brand |
5 |
|
Risk Ratio (IV, Random, 95% CI) |
Subtotals only |
| 8.4.1 From 0 to 42 days after vaccination (Priorix) |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
1.95 [0.85, 4.48] |
| 8.4.2 From 7 to 10 days after vaccination (Priorix) |
1 |
|
Risk Ratio (IV, Random, 95% CI) |
1.69 [0.93, 3.07] |
| 8.4.3 From 0 to 42 days after vaccination (ProQuad) |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
1.30 [1.17, 1.44] |
| 8.4.4 From 7 to 10 days after vaccination (ProQuad) |
4 |
|
Risk Ratio (IV, Random, 95% CI) |
2.01 [1.70, 2.38] |
| 8.5 MMRV versus MMR |
6 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Subtotals only |
| 8.5.1 From 0 to 42 days after vaccination |
5 |
|
Risk Ratio (IV, Fixed, 95% CI) |
1.53 [1.37, 1.71] |
| 8.5.2 From 7 to 10 days after vaccination |
6 |
|
Risk Ratio (IV, Fixed, 95% CI) |
1.50 [1.36, 1.66] |
| 8.6 MMRV versus MMR ‐ by brand |
6 |
|
Risk Ratio (IV, Fixed, 95% CI) |
Subtotals only |
| 8.6.1 From 0 to 42 days after vaccination (Priorix) |
2 |
|
Risk Ratio (IV, Fixed, 95% CI) |
1.28 [1.00, 1.64] |
| 8.6.2 From 7 to 10 days after vaccination (Priorix) |
2 |
|
Risk Ratio (IV, Fixed, 95% CI) |
2.49 [1.66, 3.74] |
| 8.6.3 From 0 to 42 days after vaccination (ProQuad) |
3 |
|
Risk Ratio (IV, Fixed, 95% CI) |
1.60 [1.42, 1.82] |
| 8.6.4 From 7 to 10 days after vaccination (ProQuad) |
4 |
|
Risk Ratio (IV, Fixed, 95% CI) |
1.46 [1.32, 1.61] |
